FDA allows marketing of first medical device to prevent migraine headaches

by Press Release The US Food and Drug Administration March 12, 2014

Normal
0

false
false
false

EN-US
X-NONE
X-NONE

MicrosoftInternetExplorer4

Yesterday, the U.S. Food and Drug Administration allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain.

<w:LsdException Locked=”false” UnhideWhenUse

<!–

–>